Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fract...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/dc16db73d1cb4e6f8503783122d9df53 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|